Hematology-Oncology396

Pub YearTitleAJOU Author(s)
2013Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905).강석윤
2015Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04.최진혁
2004Mutant p53 protein in the serum of patients with cervical carcinoma: correlation with the level of serum epidermal growth factor receptor and prognostic significance.최진혁
2015Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome.박준성
2024Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial강석윤
2010New drugs in hematological disorders박준성, 정성현
2018OA10.05: An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09)이현우
2024Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study이현우
2020Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia박준성
2015Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation.강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁
2020Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)안미선
2009Outcome of Locally Advanced Esophageal Cancer Treated with Concurrent Chemo-radiotherapy강석윤, 강승희, 오영택, 전미선, 최진혁
2023Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts정성현, 최윤석
1996Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain.최진혁
2022Oxaliplatin (3 months v 6 months) with 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients with Stage II/III Colon Cancer: KCSG CO09-07강석윤
2018P1.15-14: Pneumonia in Patients with Lung Cancer of South Korea: A Nationwide Population Based Study이현우, 정준호, 허재성
2023p15INK4B is an alternative marker of senescent tumor cells in colorectal cancer김영화, 김장희, 박태준, 신준상, 이영경, 임수빈, 최용원
2018P2.12-01: Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study최진혁
2019Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial강석윤
1995Patency of a small vessel prosthesis bonded to tissue plasminogen activator and iloprost.김효철

Browse